BBK Worldwide, a clinical trial marketing firm announced it is making the availability of its mobile apps My Clinical Study Buddy®for patients and My Protocol Pal® for investigators free of charge throughout 2015.
BBK Makes Mobile App Suite Available Free of Charge
BBK Worldwide, a clinical trial marketing firm announced it is making the availability of its mobile apps My Clinical Study Buddy® for patients and My Protocol PalSM for investigators free of charge throughout 2015. BBK’s mobile apps are built on its cloud-based content management engine, TrialCentralNetSM (TCN®), to help companies reduce enrollment timelines and provide insight into key patient recruitment pressure points. What’s more, BBK’s engagement solutions, RSG® Card and RSG® Arrive are also available through TCN for a seamless connection to My Clinical Study Buddy®. These offerings allow the study community to more easily reimburse and arrange travel for relevant studies, a major and often overlooked bottleneck for sites and sponsors – especially with the complex travel and reimbursements inherent in rare disease trials.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.